SP, page-15

This whole med imaging segment is getting a strong bid this FYTD on the ASX. Hard to see why not given the qualities of these companies when they succeed in market with leading products that prove useful to clinicians.

PME has ripped since its last deal. VHT is getting on more radars with strong promotion from key brokers Morgans and Bells which drives the ongoing bid between quarterly reports. It has the characteristics to go mainstream to instos like PME has through its rise. There is another little med imaging company listed on the ASX, more a peer to PME, that could offer another early opportunity before the market catches up to it.